Birinyi Associates’s Gilead Sciences GILD Stock Holding History

Birinyi Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Hold	1,600	–	–	0.05%	61
2026 Q1	$223K	Sell	1,600 -361	-18%	-$50.6K	0.06%	59
2025 Q4	$241K	Buy	+1,961	New	+$238K	0.06%	57
2016 Q3	–	Sell	-6,350	Closed	-$529K	–	87
2016 Q2	$529K	Sell	6,350 -1,450	-19%	-$129K	0.23%	60
2016 Q1	$717K	Sell	7,800 -1,150	-13%	-$104K	0.32%	53
2015 Q4	$906K	Sell	8,950 -3,100	-26%	-$323K	0.59%	44
2015 Q3	$1.18M	Buy	12,050 +5,550	+85%	+$616K	0.51%	43
2015 Q2	$761K	Sell	6,500 -3,350	-34%	-$366K	0.52%	45
2015 Q1	$967K	Sell	9,850 -1,100	-10%	-$112K	0.64%	39
2014 Q4	$1.03M	Buy	10,950 +2,600	+31%	+$269K	0.46%	41
2014 Q3	$889K	Buy	8,350 +4,750	+132%	+$465K	0.4%	42
2014 Q2	$298K	Buy	+3,600	New	+$280K	0.14%	76
2013 Q4	–	Sell	-1,600	Closed	-$101K	–	82
2013 Q3	$101K	Buy	+1,600	New	+$95.6K	0.06%	95

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Birinyi Associates's GILD Position: Q2 2026 in Review

Birinyi Associates held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,600 shares worth $202K. The position accounts for 0.05% of the portfolio, ranked #61.

Birinyi Associates first reported a position in GILD in Q3 2013 and has held it in 13 quarters since. The position peaked at $1.18M in Q3 2015. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Birinyi Associates held 1,600 shares of Gilead Sciences worth $202K as of Q2 2026.
Birinyi Associates left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.05% of Birinyi Associates's portfolio in Q2 2026, its #61 holding.
Birinyi Associates first reported a position in Gilead Sciences in Q3 2013 and has held it in 13 quarters since.
Birinyi Associates's Gilead Sciences position peaked at $1.18M in Q3 2015.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Birinyi Associates's 13F filing for Q2 2026, filed 5 Aug 2026.